fda warning letters bpc-157 compounding pharmacies Heal or Harm: Body Protective Compound-157 in the Gray Zone Partnership for Safe Medicines urges
Description
Of the 14 semaglutide-treated patients that developed anti-semaglutide antibodies, 7 patients (0.2% of the overall population) developed antibodies cross-reacting with native GLP-1
Compounded semaglutide has grown in popularity during shortages, but compounded drugs are not approved by the Food and Drug Administration (FDA)
In regards to ruminants raised in factory farms (more properly known as CAFOs or Confined Animal Feeding Operations), they also only need the mineral cobalt to be supplemented in their diet
doi: 10.1016/j.clim.2011.11.004
